Fundraising Fox
Epigenic Therapeutics
Founded 2021 · 17 employees on LinkedIn · 3 known investors
Find your way into Epigenic Therapeutics
Sign up to see every warm intro you have to Epigenic Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Epigenic Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.
Founders & leadership
Investors · 3
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Epigenic Therapeutics do?
- Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.
- Who are Epigenic Therapeutics's investors?
- Epigenic Therapeutics's investors include OrbiMed, Qiming Venture Partners, Trinity Innovation Bioventure Singapore.